Thrivent Financial for Lutherans’s KalVista Pharmaceuticals KALV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-13,623
Closed -$107K 2501
2023
Q1
$107K Hold
13,623
﹤0.01% 2413
2022
Q4
$92K Buy
+13,623
New +$92K ﹤0.01% 2387